Influenza Infection

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-04-08
Clinical Trial Update: Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age [Phase 1]
A Phase 1 clinical trial in adults 18-49 is evaluating two vaccine formulations encoding the RSV monovalent antigen or the influenza A(H5) a…